Detalhe da pesquisa
1.
CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trial.
Respir Res
; 21(1): 149, 2020 Jun 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32532258
2.
Efficacy and safety of once-daily GW870086 a novel selective glucocorticoid in mild-moderate asthmatics: a randomised, two-way crossover, controlled clinical trial.
J Asthma
; 50(10): 1077-82, 2013 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-23991670
3.
A randomized, parallel-group study to evaluate the efficacy of umeclidinium/vilanterol 62.5/25 µg on health-related quality of life in patients with COPD.
Int J Chron Obstruct Pulmon Dis
; 11: 971-9, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27274218
4.
Effects of a combination of umeclidinium/vilanterol on exercise endurance in patients with chronic obstructive pulmonary disease: two randomized, double-blind clinical trials.
Ther Adv Respir Dis
; 8(6): 169-81, 2014 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-25452426